Skip to main content
SpringerLink
Log in

Reduced efficacy of sulfitolysed intravenous immunoglobulin

  • Correspondence
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gtonski, P., Hofstaetter, T., Kanzy, E. J., Lüben, G., Seiler, F. R.: S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. I.: Physicochemical and binding properties of S-sulfonated and reconstituted IgG. Vox Sanguinis 1983, 45: 144–154.

    PubMed  Google Scholar 

  2. Stephan, W.: Undegraded human immunoglobulin for intravenous use. Vox Sanguinis 1975, 28: 422–437.

    PubMed  Google Scholar 

  3. Bradley, J. V.: Wilcoxon's Rank-Sum test for identical populations, sensitive to unequal locations. In: Bradley, J. V. (ed.): Distribution-free statistical tests. Prentice-Hall, Englewood Cliffs, NJ, 1968, p. 105–114.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biotest Pharma GmbH, Flughafenstraße 4, 6000, Frankfurt am Main 73, FRG

    W. Stephan & H. Dichtelmüller

Authors
  1. W. Stephan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Dichtelmüller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stephan, W., Dichtelmüller, H. Reduced efficacy of sulfitolysed intravenous immunoglobulin. Eur. J, Clin. Microbiol. 3, 47 (1984). https://doi.org/10.1007/BF02032820

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02032820

Keywords

Search

Navigation